enable greater control over drug delivery compared to traditional systems that cannot be modified in response to changing therapeutic needs (e.g., systems based on biodegradability of polymers).
Introduction
Electroactive conducting polymers (ECPs) allow excellent control of the electrical stimulus, possess very good electrical and optical properties, have a high conductivity/weight ratio and can be biocompatible, biodegradable, and porous. [1] Furthermore, a great advantage of ECPs is that their properties can be tailored to the specific needs of their applications by incorporation of biopolymers, peptides, or other biorelated moieties. [2] On the other hand, on-demand release of drug molecules from biomedical devices enables precise targeted dosing that can be temporally tuned to meet requirements for a variety of biomedical applications. [3, 4] Recent advances have facilitated the use of different stimuli, such as light, magnetic and electric fields, ultrasounds and electrochemical signals, to trigger drug release from smart material formulations (e.g., films, microand nanoparticles, and implant devices). [4, 5] These technologies www.advancedsciencenews.com www.advhealthmat. de has been used to trigger sensitive dosage-controlled release of drugs. [6, 14, 15] More specifically, the response of PPy NPs embedded in a hydrogel against a dual stimulus (temperature and electric field) was demonstrated through in vivo experiments. [6] Additionally, the on demand release of drugs with different polarities and molecular weights from electroresponsive PPy NPs has been evaluated. [14] The biocompatibility and linear response achieved with a repetitive and pulsed release evidenced that such approaches are facile and minimally invasive for potential medical applications. [6, 14] Besides, the pH-sensitive behavior of drug-loaded PPy NPs has been also reported, [15] reflecting that the release can be controlled through the pH, the charge of the drug and/or the addition of charged amphiphiles. Among ECPs, poly(3,4-ethylenedioxythiophene) (PEDOT) is probably the most employed for the fabrication of biomedical devices because of its outstanding capacitive performance, fast doping-undoping process, stable charge-discharge response, and high conductivity, biocompatibility, and stability in continuous operation. [16] [17] [18] The structure, surface morphology, and porosity of PEDOT, and the above discussed PPy are completely different [17, 19] since the former is exclusively formed by α,α-linkages while the latter is highly crosslinked. Consequently, both the electrochemical and electrical responses of PEDOT are greatly superior to those of PPy. In spite of these advantages, the loading of drugs into PEDOT NPs for release on demand remains practically unstudied. Paradee and Sirivat [20] examined the electrically controlled release of benzoic acid loaded on PEDOT NPs blended with alginate hydrogels. More recently, Liu et al. [21] loaded 2-phenylethynesulfonamide, which is a heat shock protein 70 (HSP70) inhibitor, into thermoresponsive poly(N-isopropylacrylamide) shells, incorporating PEDOT NPs as a photothermal coupling agent.
In this work, two neutral and hydrophobic drugs have been loaded into PEDOT NPs (drug/PEDOT NPs) during their synthesis by emulsion polymerization in water. These drugs are curcumin (CUR), which displays a wide spectrum of medical properties ranging from antibacterial, antiviral, antiprotozoal, antifungal, and anti-inflammatory to anticancer activity, [22] and piperine (PIP), a piperidine alkaloid with pharmacological properties as anti-inflammatory, antifertility, and stimulator of serotonin synthesis in the central nervous system, among others. [23] The release of the drugs from the ECP NPs has been investigated without and with electrostimulation. Results have demonstrated that PEDOT NPs loaded with CUR serve as a drug reservoir for electric-field triggered release.
Results and Discussion
Although different approaches have been proposed to synthesize ECP NPs from their corresponding monomers combined with soft templates, [24] they have been criticized because of the poor control on both size and colloidal stability. Moreover, the difficulty of getting rid of the surfactant is added. [25] In a recent study, Zhou and co-workers prepared PEDOT NPs with a particle size distribution of 17.2 ± 1.6 nm applying a hydrothermal approach and using FeCl 3 ·6H 2 O as an oxidant and sodium dodecyl benzene sulfonate as a stabilizer. [26] In this study, PEDOT NPs have been obtained in water at 40 °C using dodecyl benzene sulfonic acid (DBSA) as a stabilizer and a doping agent simultaneously, and ammonium persulfate (APS) as an oxidizing agent (Figure 1b) . It is worth noting that the stabilizer is required to avoid the yielding of the ECP as an insoluble bulk powder with very limited processability. [27] The effective diameter (D eff ) of the resulting PEDOT NPs, which are displayed in Figure S1 (Supporting Information), was 35 ± 6 and 84 ± 2 nm, as determined by scanning electron microscopy (SEM) and dynamic light scattering (DLS), respectively.
The two drugs, CUR and PIP (Figure 1c ), considered in this work were loaded in situ during the emulsion polymerization. Due to their hydrophobicity, the drugs remained into the cores of the surfactant micelles rather than interacting with the medium. After polymerization, PEDOT NPs were formed and drugs were successfully loaded. The drug loading ratio (DLR), which was expressed as mass of encapsulated drug with respect to the total mass, was 5.9 ± 1.6% and 8.0 ± 0.4% for CUR and PIP, respectively, these values being similar to those achieved using other polymeric vesicles. [28] Moreover, the successful loading of the drugs within the PEDOT NPs was further confirmed by FTIR spectroscopy, discussed afterward.
CUR-and PIP-loaded PEDOT NPs, hereafter denoted as CUR/PEDOT and PIP/PEDOT NPs, respectively, are spherical and stable in solution (Figure 2) . Despite the CUR and PIP are neutral, hydrophobic and of similar size (i.e., 368.4 and 285.3 g mol −1 , respectively), the average effective diameter (D eff ) of loaded NPs was found to be considerably affected by the drug, as observed by DLS measurements and SEM measurements. Table 1 reflects that the CUR/PEDOT NPs are small and monodisperse (i.e., D eff with low standard deviation), whereas PIP/PEDOT NPs are relatively large and polydisperse (i.e., D eff with high standard deviations). The yielded NPs and their corresponding aggregates successfully remained below 4 µm, which is the smallest diameter of human blood capillaries, [29] and thus avoiding the blockage of blood vessels or the possibility of being eliminated by the body reticuloendothelial system. SEM and DLS observations are corroborated by the atomic force microscopy (AFM) images displayed in Figure 3 , which reflect remarkable differences among PEDOT, CUR/PEDOT, and PIP/PEDOT NPs. Thus, PEDOT NPs remained stable and very small while CUR/PEDOT and, especially, PIP/PEDOT exhibited higher size and tendency to aggregate. The size increment is probably due to the extremely low aqueous solubility of the two drugs, which promotes the formation of relatively large molecular cores inside PEDOT NPs. The tendency to aggregate is corroborated by the zeta-(ζ-) potential, which varies as follows: PEDOT < CUR/PEDOT < PIP/PEDOT (Table 1 ). The physical stability of an aqueous dispersion is considered to be good when the absolute value of the ζ-potential is around 30. [30] Therefore, the colloidal stability of CUR/PEDOT and PIP/ PEDOT NPs (ζ-potential of −26.5 ± 5.1 and −18.7 ± 3.0 mV, respectively) is lower than that of PEDOT NPs (−29.4 ± 3.6 mV).
FTIR spectroscopy has been used to determine the chemical structure of the functional groups on the surface of PEDOT NPs. Figure 4 displays the FTIR spectra recorded for drugs, PEDOT NPs, and drug/PEDOT NPs. PEDOT NPs doped with DBSA exhibit the main absorption peaks from the thiophene, ether, and sulfonate groups: stretching modes of CC in the thiophene ring at 1647 and 1557 cm −1 , CH 2 stretching modes at 1478, 1396, and 750 cm −1 , COC vibrations at 1206 and 1057 cm −1 , and the SO stretch at 667 cm −1 . The addition of drugs during the polymerization process did not affect the localization of PEDOT bands; instead, the bands associated with the individual drugs were appreciated proving their incorporation. The two main characteristic CO stretching bands at 1626 and 1535 cm −1 and the enol CO peak at 1267 cm −1 observed for CUR alone are also detected in CUR/PEDOT NPs ( Figure 4a) . Similarly, the very broad band at 3293 cm −1 and the sharp peak at 3508 cm −1 indicate the presence of OH, whereas the peaks at 959 and 713 cm −1 have been attributed to the benzoate trans-and cisCH vibrations, respectively. Finally, the FTIR spectrum of free PIP (Figure 4b Dialysis bags with a molecular weight cutoff of 3500 kDa were used to understand the kinetics of the nonstimulated drug release in different media ( Figure 5 ). In order to achieve a complete CUR and PIP release, three different environments with increasing affinity for the drug were examined: PBS with 0.5% Tween 20 (which is a surfactant that helps the dissolution of the drug), and the same solution mixed with 10% ethanol (EtOH) and with 70% EtOH. Comparison of the released amount of drug from drug/PEDOT NPs with their respective controls (i.e., drugs alone) allows to visualize a different behavior for CUR and PIP when interact with PEDOT. More specifically, the release of CUR from CUR/PEDOT NPs was much slower than that of PIP from PIP/PEDOT NPs with respect to their corresponding controls. These results reflect a relatively strong interaction between CUR and PEDOT, making difficult the release of the drug from the NPs until an environment with a high alcoholic content is used (Figure 5a) . Instead, the release of PIP from the NPs was very similar to that of the control, indicating a simple diffusion phenomenon motivated by the poor affinity between the drug and the ECP. This feature is confirmed by the almost imperceptible effect of the increment of EtOH in the release medium (Figure 5b ). The divergent behavior of CUR/PEDOT and PIP/PEDOT should be attributed to the different hydrogen bonding abilities of the two drugs. Thus, CUR···PEDOT hydrogen bonds are expected to be formed between the hydroxyl groups of CUR (Figure 1c ) and the dioxane rings of PEDOT. It should be noted that this kind of specific interactions were found to play a crucial role in DNA···PEDOT interactions, [31] which are highly dependent on the DNA sequence. In contrast, the absence of groups able to act as hydrogen bonding donors in PIP precludes the formation of PIP···PEDOT hydrogen bonding interactions. Overall, these results suggest that CUR/PEDOT NPs are promising candidates to behave as electrically responsive drug delivery systems.
Before of the electrostimulation studies, the electrochemical response of CUR, PIP, and both PEDOT and drug/PEDOT NPs was examined by cyclic voltammetry (CV), registering oxidation-reduction cycles within the potential range of −1.5 to +1 V at different scan rates. Figure 6a (left) displays a photograph of the three electrode configuration when CV was recorded from CUR/PEDOT NPs deposited on GCE. Interestingly, it was possible to visualize the release of CUR from the NPs when low scan rates were employed.
Cyclic voltammograms recorded for CUR and PIP are displayed in Figure S3a ,b (Supporting Information), respectively. Since CUR molecule contains two hydroxyl groups a conjugation effect can occur from the electron cloud deviation. As can be it seen CUR exhibits one well-defined anodic peak at a potential of ≈+0.4 V and a less defined cathodic peak at ≈−0.10 V ( Figure S3a , Supporting Information), which are similar to that previously observed elsewhere. [32] These quasi-reversible peaks have been attributed to the product of the irreversible oxidation reaction, which can be adsorbed onto the electrode surface. The intensity of the peaks increases in absolute value with the scan rate and, in addition, the peaks potential shift slightly indicating that they correspond to a quasi-reversible redox process. [33] Instead, the voltammograms recorded for PIP exhibit two irreversible anodic peaks at 0.12 and 0.92 V. Cyclic voltammograms of PEDOT, CUR/PEDOT, and PIP/ PEDOT NPs adsorbed onto glassy carbon electrodes are compared in Figure 6b -d. The current density increases proportionally with the scan rate suggesting that the electrochemical process depends on the diffusion. [34] Moreover, detailed inspection of the voltammograms recorded for CUR/PEDOT NPs allows identification of the CUR anodic peak at a potential between 0.4 and 0.5 V, depending on the scan rate. Figure 6e plots the current density at the anodic and cathodic peaks (j p ) of CUR against the square root of the scan rate, while Figure 6f represents the same graphic for the irreversible anodic process of PIP at 0.92 V. A linear behavior is observed in all cases. Moreover, in the case of CUR the slope was slightly higher for the anodic process than for the cathodic one. These results confirm the dependence of electrode reaction on the diffusion, which is the mass transport rate of the electroactive species to the surface of the electrode across a concentration gradient.
Experiments with electrostimulation were performed using a conventional three-electrode setup, similar to that displayed in Figure 6a , with glassy carbon coated with drug/PEDOT NPs as working electrode (WE), bare glassy carbon as a counter electrode (CE), and Ag|AgCl as a reference electrode (RE). To investigate the effect of the voltage on the release of CUR and PIP from drug/PEDOT NPs, different voltages (i.e., 0.50, −0.50, −1.00, and −1.25 V) were applied during 3 min. Results have been compared with control experiments, which were performed in absence of electric voltage (hereafter denoted 0.00 V). In order to mimic a physiological medium, electrically stimulated drug release experiments were performed using PBS 1 with 0.5% (v/v) Tween 20 at pH 7.4 as an electrolyte medium.
Results found for CUR and PIP, which are displayed in Figure 7a www.advancedsciencenews.com www.advhealthmat.de amount of encapsulated CUR was lower than 5% when the applied voltage was 0.50 V or in absence of stimulus, while increased progressively and linearly with the more negative voltage. Thus, the stimulation with −1.25 V for 3 min resulted in a CUR delivery of 38%. In the case of PIP/PEDOT NPs, the amount of released drug in absence of stimulus is 10%, increasing to 18% and 23% when the applied voltage is −0.50 and 0.50 V, respectively. No systematic behavior was identified in the case of PIP (Figure 7b ), indicating that the release of this drug cannot be controlled and programmed through electrostimulation. Figure 7c ,d displays the release of CUR and PIP, respectively, from drug/PEDOT NPs with time. Results from these experiments, which were performed using a fixed voltage of −1.25 V, are consistent with those reported in Figure 7a ,b, indicating that controlled release by electrical stimulation can be efficiently achieved only for CUR. Thus, although 7% of CUR is released after 30 s only, the amount of released drug increases logarithmically with time. In the time interval compressed between 3 and 9 min, the release grows from 38% to 60%. Also, complementary assays showed that the CUR release stops when the voltage is tuned off, proving that this is a regulated process. These results reflect that the controlled CUR release can be achieved with both time and applied potential (Figure 7a,c, respectively) . Release profiles were reproducible not only with as fresh samples but also with suspensions that were stored for even one month before the release assays. The variation of PIP release with time is practically null (i.e., 20% after both 3 and 9 min), corroborating that the poor interactions between such drug and the ECP preclude Previous studies suggested that the take-up and rate delivery of drugs may depend on the structure, composition, and oxidation state of the ECP. [11] In the particular case of the release of charged drugs by electrical stimulation, the main factor is the oxidation state since the driving force of this process is the apparition of repulsive drug···ECP electrostatic inter actions. Thus, the oxidation and reduction of the ECP cause the release of cationic and anionic drugs, respectively. [11] However, CUR and PIP are neutral drugs at pH 7 and, therefore, their electrically stimulated release is expected to be controlled by a more complex mechanism. Unfortunately, designs allowing for the controlled release of neutral drugs are very scarce. Langer and co-workers [35] used biotin-doped PPy to load biotinylated nerve growth factor (NGF) at the biotin binding sites found at the polymer surface. Reduction of the PPy film resulted in an electrically triggered NGF release, which remained biologically active. On the other hand, N-methylphenpthiazine (NMP) loaded into PPy doped with anionic β-cyclodextrins was released when oxidized, which caused the formation of positive charges on both the ECP and NMP. [36] The mechanism proposed in this work for the electrically stimulated release of CUR is based on the effect of the voltage on the oxidation state of the ECP and, therefore, on PEDOT···CUR interactions. The release of CUR is not stimulated by the application of the positive voltage (+0.50 V), which enhances the positive oxidation state of the polymer ( Figure S3 , Supporting Information) while the oxidation of the drug starts at around such potential ( Figure S3, Supporting Information) . In contrast, the CUR release becomes electrostimulated upon the application of negative voltages, which induce the electrochemical dedoping (reduction) of PEDOT NPs. Thus, the fraction of reduced PEDOT sites over the number of total active sites (i.e., where electrons are exchanged) increases with the negative voltage, polymer chains being expected to be completely, or almost completely, reduced (i.e., dedoped-with neutral charge) at the voltage of −1.25 V. [34] It was observed that lower voltages caused mechanical and electrochemical degradation of the ECP NPs. The dedoping of the ECP affects the intermolecular interactions with the drug, hydrogen bonds being significantly weaker when PEDOT chains are in the neutral state than in the oxidized state. [37] Accordingly, the mechanism for the electrostimulated CUR release from CUR/PEDOT NPs can be summarized by the following Equation (1)
where nCUR refers to the drug molecules hydrogen bonded to the oxidized polymeric NPs, mCUR corresponds to the drug molecules that remain hydrogen bonded to the polymeric NPs after pump β electrons into the system by electrical stimulation, and α+ and (α−β)+ are the oxidation states of oxidized and reduced PEDOT, respectively (i.e., when PEDOT is completely reduced, α = β, the charge of the ECP is zero. The release mechanism proposed in this work for neutral drugs able to form specific interactions with the ECP matrix resembles that typically reported when negatively charged drugs act as dopant ions. [8] Unfortunately, this mechanism does not apply to PIP/PEDOT NPs because of the lack of hydrogen bonding donors in the drug. Accordingly, PIP molecules are rapidly released by through the walls of the polymeric NPs, such diffusion process being independent of the presence or not of external stimuli. Thus, although the application of an electric voltage affects the oxidation state of PEDOT chains, it does not improve the control in the release that is determined by the intrinsically weak dispersion interactions between PIP molecules and the aromatic rings of the ECP. In order to overcome the limitations associated with the instability in the light, poor oral bioavailability in vivo and lack of solubility in aqueous solvents of CUR, the use of microand nanoparticles made of polymer materials, as for example poly(lactic-co-glycolic acid), as carriers has been extensively explored. [38] Although polymeric micro-and nanoparticles provided biocompatibility, in some cases also biodegradable, platforms for sustained release of CUR with improved bioavailability, several disadvantages were detected. The most important one, which is the effective control during the release, has been overcome in this work applying a controlled voltage to electrodes coated with CUR/PEDOT NPs, achieving a programmed CUR release.
The biocompatibility and cytotoxicity of such system is an important characteristic to be analyzed for further biological applications. PEDOT NPs and the surfactant (DBSA) alone were tested in epithelial-like prostate and breast adenocarcinoma cells lines from human (PC3 and MCF-7, respectively) using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assayassay measured after 24 h post-treatment (Figure 8a) . PEDOT NPs do not exhibit any toxic effect until they are used at high concentration. Moreover, it is clearly demonstrated that, after the three washing steps, the quantity of dopant is lower than 6 µg mL −1 , when DBSA starts to be toxic. The cytotoxicity of free CUR and CUR/ PEDOT NPs, which was evaluated at 24 h posttreatment using the same cell lines, reflects significant concentration dependence (Figure 8b ). Significant differences are observed in the behaviour of the two systems, free CUR being considerably more toxic than CUR/PEDOT NPs. More specifically, for PC3 the half-maximal inhibitory concentration (IC50) of the former and the latter is around 20 and 100 µg mL −1 , respectively, while for MCF-7 both are around 10 µg mL −1 . These results, combined with the fact that the drug loaded inside the NPs is only partially released in absence of external stimuli, corroborate that PEDOT nanostructures formed by emulsion polymerization is a very interesting electroactive vehicle for the controlled delivery of neutral drugs having groups able to interact with hydrogen bonds. In order to explore the mechanisms of cytotoxicity, the cellular uptake of free CUR and CUR/PEDOT NPs on PC3 and MCF-7 cells was observed by fluorescence microscopy. Figure 9 shows the images of nontreated cells, PEDOT NPs treated, free CUR treated and CUR/PEDOT treated for 24 h. Medium without treatment drug was regarded as control, as well as, the PEDOT NPs treated group. Both groups did not present any fluorescence at any point and there was not any diminish in cell nucleus number. In contrast, an intense fluorescence was observed at the cell cytosol after 24 h for free CUR and CUR/PEDOT NPs. In addition, the two groups exhibited lower number of cell nuclei than before the treatment had been executed. Besides, different cellular morphologies were observed: cells treated with free CUR presented more rounded bodies, denoted by high circularity (Figure 9c ), than cells treated with CUR/PEDOT. These results suggest that cells were more affected by free CUR than when it is encapsulated within the PEDOT NPs, again indicating that the complete effect of the drug would not be achieved until it is stimulated.
Overall, results obtained in this paper indicate that CUR/ PEDOT NPs can be considered as potential controlled release systems for therapeutic applications based on the antibacterial, antiviral, antiprotozoal, anti-inflammatory, or anticancer activity of CUR. This system allows a given dosage at desired periodical time by applying a harmless external voltage of only −1.25 V (i.e., from a conventional small battery). Moreover, after its optimization to reduce a little bit more the required voltage, one could envision advanced biomedical applications of the CUR/ PEDOT NPs system using the weak electric fields naturally occurring in the body for stimulation (e.g., the intrinsic electric fields of cardiovascular and neuronal tissues). 
Conclusions
Encapsulation of CUR and PIP in PEDOT NPs was achieved by in situ emulsion polymerization using DBSA as stabilizer and doping agent. The release behaviour of these two neutral drugs, which only differ in their capacity to form hydrogen bonding interactions with the oxidized polymer chains, was very different in absence and in presence of external electrostimulation. The release of CUR is controlled through the strength of such specific drug···ECP interactions, which become weaker when polymer chains are reduced applying an external negative voltage. Therefore, CUR/PEDOT NPs are a promising combination that efficiently controls the release of the drug through external stimuli. This methodology, which can be extrapolated to other neutral drugs with similar hydrogen bonding abilities, may be a potential strategy for treatments based on the programmed dosage of CUR that, among many other medicinal properties, have demonstrated efficacy as anticancer agent for many types of malignancies, including colorectal, breast, lung, prostate, and pancreatic carcinoma.
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